Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Bull Entomol Res ; 100(3): 297-302, 2010 Jun.
Article in English | MEDLINE | ID: mdl-19781113

ABSTRACT

Traditional approaches to studying the effects of genetically modified (GM) crops on beneficial insects involve either field assays, comparing insect population levels between control and GM crops or tritrophic bioassays with contaminated insects - usually larvae or eggs of Lepidoptera - as preys. Here, we report the results of a bioassay using an artificial diet, suitable for predatory Coleoptera, to supply Bacillus thuringiensis (Bt) solubilized Cry1Ab and Cry3Aa as well as trypsin-activated Cry1Ab to Atheta coriaria and Cryptolaemus montrouzieri adults and young larvae of Adalia bipunctata. Water, solubilization buffer and trypsin-treated solubilization buffer were used as controls. In total, 1600 insects were assayed. Assays showed a relatively low mortality rate in the controls, ranging from as low as 7% after 15 days (C. montrouzieri) to about 15-20% after five days (A. bipunctata) or 15 days (A. coriaria). For all three predators, there were no statistical differences between the mortality recorded in any of the treatment groups and the corresponding controls. These results indicate a lack of short- (A. bipunctata) and long-term (A. coriaria and C. montrouzieri) mortality associated with oral ingestion of Cry1Ab and Cry3Aa at the high dose tested (50 microg ml-1). We discuss the relevance of these findings for the ecology of beneficial Coleoptera and compatibility with Bt and GM Bt crops.


Subject(s)
Bacillus thuringiensis/chemistry , Bacterial Proteins/toxicity , Coleoptera/drug effects , Endotoxins/toxicity , Hemolysin Proteins/toxicity , Animals , Bacillus thuringiensis Toxins , Biological Assay , Diet , Larva , Pest Control, Biological/standards , Predatory Behavior , Survival Analysis
2.
Neuropharmacology ; 51(5): 967-73, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16949621

ABSTRACT

3,4-Methylenedioxymethamphetamine (MDMA) is a potent stimulant and hallucinogenic drug whose ability to regulate neurogenesis in the adult has not been previously investigated. We used 5'-bromo-2-deoxyuridine (BrdU) and Ki-67 as mitotic markers, and doublecortin (DCX) as a marker of immature neurons, to study proliferation, survival and maturation of adult-generated cells in the dentate gyrus (DG) of the hippocampus following binge administration of MDMA (8 injections of 5 mg/kg at 6 h intervals). The results showed that MDMA treatment did not affect cytogenesis in the DG, but significantly decreased the survival rate of cells incorporated after 2 weeks to the granular layer of the DG by ca. 50%, and of those remaining in the subgranular layer by ca. 30%. Two weeks after exposure to MDMA the length of dendritic arbors and the number of dendritic branches of immature DCX+ neurons were nearly identical to those of control rats, as was the level of colocalization of BrdU with DCX. These results demonstrate that binge MDMA administration does not affect the proliferation rates of progenitor cells in the DG, but has deleterious effects on adult neurogenesis by impairing the short-term survival of vulnerable neural precursors.


Subject(s)
Dentate Gyrus/pathology , Hallucinogens/administration & dosage , N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage , Neurons/drug effects , Stem Cells/drug effects , Analysis of Variance , Animals , Behavior, Animal/drug effects , Bromodeoxyuridine/metabolism , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Survival/drug effects , Dentate Gyrus/drug effects , Doublecortin Domain Proteins , Doublecortin Protein , Immunohistochemistry/methods , Ki-67 Antigen/metabolism , Male , Microtubule-Associated Proteins/metabolism , Neuropeptides/metabolism , Rats , Rats, Wistar
3.
Eur J Neurosci ; 24(2): 586-94, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16903860

ABSTRACT

Recent observations indicate that drugs of abuse, including alcohol and opiates, impair adult neurogenesis in the hippocampus. We have studied in rats the impact of cocaine treatment (20 mg/kg, daily, i.p.) on cell proliferation, survival and maturation following short-term (8-day) and long-term (24-day) exposure. Using 5'-bromo-2-deoxyuridine (BrdU) and Ki-67 as mitotic markers at the end of the drug treatments, we found that both short- and long-term cocaine exposures significantly reduced cell proliferation in the dentate gyrus (DG) of the hippocampus. By labelling mitotic cells with BrdU pulses before or during the early stages of the drug treatment, we determined that long-term cocaine exposure did not affect the survival of newly generated cells. In register with this finding, cocaine chronic exposure did not increase the number of apoptotic cells labelled by TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling). Using doublecortin (DCX) immunocytochemistry and electron microscopy, we next examined the effects of cocaine exposure on the maturation of the neural precursors and on synaptic output to CA3. DCX immunocytochemistry showed that immature hippocampal cells of rats exposed to cocaine displayed normal arborization patterns and similar degrees of colocalization with BrdU at two different developmental stages. Moreover, cocaine did not produce significant morphological alterations of the mossy fibre projection system to stratum lucidum in the CA3 area of the hippocampus. The results presented demonstrate that chronic cocaine exposure impairs proliferation dynamics in the DG without significantly altering either the survival and growth of immature cells or the structural features of terminal projections to CA3.


Subject(s)
Cocaine-Related Disorders/physiopathology , Cocaine/adverse effects , Dentate Gyrus/drug effects , Neurons/drug effects , Stem Cells/drug effects , Animals , Bromodeoxyuridine , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Proliferation/drug effects , Cell Shape/drug effects , Cell Shape/physiology , Cell Survival/drug effects , Cell Survival/physiology , Chronic Disease , Cognition Disorders/chemically induced , Cognition Disorders/physiopathology , Dentate Gyrus/pathology , Dentate Gyrus/physiopathology , Disease Models, Animal , Dopamine Uptake Inhibitors/adverse effects , Doublecortin Domain Proteins , Doublecortin Protein , Down-Regulation/drug effects , Down-Regulation/physiology , Drug Administration Schedule , Ki-67 Antigen/metabolism , Male , Microtubule-Associated Proteins/drug effects , Microtubule-Associated Proteins/metabolism , Mitosis/drug effects , Mitosis/physiology , Mossy Fibers, Hippocampal/drug effects , Mossy Fibers, Hippocampal/pathology , Neurons/pathology , Neuropeptides/drug effects , Neuropeptides/metabolism , Rats , Rats, Wistar , Stem Cells/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...